U.S. Ketamine Clinics Market Size to Hit US$ 5.91 Billion at a CAGR of 10.60% by 2028
How Big Is the U.S. Ketamine Clinics Market?
The
U.S. ketamine clinics market size reached US$ 3.24 Billion in 2022.
Looking forward, IMARC Group expects the market to reach US$ 5.91 Billion
by 2028, exhibiting a growth rate (CAGR) of 10.60% during 2023-2028.
Industry
Overview of U.S. Ketamine Clinics Market
Ketamine clinics are specialized healthcare centers dedicated to providing ketamine treatments, especially for conditions such as depression, anxiety, and various chronic pain disorders. These clinics are staffed by a team of trained medical professionals, including physicians and nurses, who oversee the administration and monitoring of ketamine infusions. Patients benefit from a safe and closely supervised setting where they can receive their ketamine treatments under the expert guidance of healthcare experts.
Request
for a PDF sample of this report: https://www.imarcgroup.com/us-ketamine-clinics-market/requestsample
U.S.
Ketamine Clinics Market Trends and Drivers:
The increasing prevalence of treatment-resistant mental health conditions such as major depressive disorder (MDD), anxiety, post-traumatic stress disorder (PTSD), and bipolar disorder is a key driver fueling market growth in the United States. Additionally, heightened awareness campaigns promoting mental health awareness among the general population are contributing to market expansion in the country. Furthermore, greater awareness among both patients and healthcare professionals regarding ketamine's effectiveness in rapidly alleviating depression symptoms and suicidal thoughts is boosting market growth. The availability of a wide range of ketamine treatment options, including intravenous infusion, intranasal spray, and oral tablets, is making ketamine more accessible to patients and driving market growth. Moreover, the increasing societal recognition and acceptance of mental health issues are positively influencing the market in the United States.
Ask
Analyst for 10% free customized report: https://www.imarcgroup.com/request?type=report&id=8356&flag=C
What
Is Included In Market Segmentation?
The
report has segmented the market into the following categories:
Breakup
by Treatment:
- Depression
- Anxiety
- PTSD
- Others
Breakup
by Therapy:
- On-Site Therapy
- Online Therapy
Breakup
by Region:
- Northeast
- Midwest
- South
- West
The
report provides a comprehensive analysis of the industry key players listed
below:
Better
U LLC, Field Trip Health and Wellness Ltd., Innerwell, Ketamine Clinics Los
Angeles, Klarisana – Ketamine Treatment Austin, Klarity Clinic, Mindbloom Inc.,
Nue Life Health PBC, NY Ketamine Infusions, Vitalitas Denver.
Related Posts:
Fantasy Sports Market Report 2023-2028
Animal Genetics Market Report 2023-2028
Milk Protein Concentrate Market Report 2023-2028
About
Us:
IMARC
Group is a leading market research company that offers management strategy and
market research worldwide. We partner with clients in all sectors and regions
to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC's
information products include major market, scientific, economic and
technological developments for business leaders in pharmaceutical, industrial,
and high technology organizations. Market forecasts and industry analysis for
biotechnology, advanced materials, pharmaceuticals, food and beverage, travel
and tourism, nanotechnology and novel processing methods are at the top of the
company's expertise.
Our
offerings include comprehensive market intelligence in the form of research
reports, production cost reports, feasibility studies, and consulting services.
Our team, which includes experienced researchers and analysts from various
industries, is dedicated to providing high-quality data and insights to our
clientele, ranging from small and medium businesses to Fortune 1000
corporations.
Contact
us:
IMARC
Group
134 N
4th St. Brooklyn, NY 11249, USA
Email:
sales@imarcgroup.com
Tel
No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
